Skip to main content

Table 1 Demographic and perioperative characteristics

From: Comparison of the effect of dexmedetomidine intrathecal injection and intravenous infusion on subarachnoid blockade during knee arthroscopy procedures: a randomized controlled trial

 

intrathecal group(n = 31)

intravenous group(n = 30)

control group(n = 29)

P

Age(years)

48.9 ± 12.33

50.73 ± 15.12

49.45 ± 12.68

0.862*,**,#

Height(cm)

165.87 ± 10.79

165.23 ± 8.85

165.72 ± 8.88

0.964*,**,#

Weight(kg)

69(59–82)

70(65–75)

73(65–79)

0.445*,**,#

BMI(kg/m2)

25.25 ± 2.90

25.90 ± 2.88

26.16 ± 2.98

0.46*,**,#

male n (%)

14(45.16)

10(33.33)

15(51.72)

0.351*,**,#

ASA grade n (%)

   

0.636*,**,#

 1

22(70.97)

18(60.00)

18(62.07)

 

 2

9(29.03)

12(40.00)

11(37.93)

 

Baseline heart rate(times/min)

74.29 ± 9.10

77.20 ± 11.41

73.69 ± 11.91

0.413*,**,#

Baseline MAP(mmHg)

100.32 ± 8.48

103.08 ± 13.26

106.09 ± 11.83

0.15*,**,#

Duration of surgery(min)

70(46–105)

77(47.75–104.25)

59(41–110)

0.813*,**,#

Type of surgery

   

0.754*,**,#

 Meniscus plasty

23

23

25

 

 Cyst removal

3

1

0

 

 Anterior cruciate ligament reconstruction

4

5

3

 

 Synoviectomy

1

1

1

 
  1. Data are expressed as mean ± SD, median (interquartile range), or number of the patients(proportion)
  2. Abbreviations: BMI, body mass index; ASA, american society of anesthesiologist; HR, heart rate; MAP, mean arterial pressure
  3. *intrathecal group versus intravenous group
  4. **intrathecal group versus control group
  5. #intravenous group versus control group
  6. P < 0.05 considered as significant